تنظیم داروهای قلبی پیش از جراحی‌های غیرقلبی

نوع مقاله : مقاله کوتاه

نویسندگان

1 متخصص قل بو عروق، فلوشیپ اینترونشن، بیمارستان مهراد

2 متخصص قلب و عروق، بیمارستان مهراد

چکیده
بیماری قلبی یکی از عوامل مهم مؤثر در پیش آگهی جراحی‌های غیر قلبی است. بیماران قلبی اغلب داروهای متنوعی دریافت می-کنند که بر شرایط و نحوه درمان قبل و بعد از عمل اثرگذاراست. امروزه با افزایش امید به زندگی، نیاز به جراحی‌های قلبی رو به افزایش است. به همین دلیل تنظیم داروهای قلبی قبل از جراحی از اهمیت ویژه‌ای برخوردار است. در این مقاله به اجمال مروری بر نحوه تنظیم داروهای قلبی قبل و بعد از جراحی غیر قلبی خواهد شد.

کلیدواژه‌ها


1. Duceppe, Emmanuelle, Parlow, Joel, MacDonald, Paul, Lyons, Kristin, McMullen, Michael, Srinathan, Sadeesh, Graham, Michelle, Tandon, Vikas, Styles, Kim & Bessissow, Amal. 2017. Canadian Cardiovascular Society Guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery. Canadian Journal of Cardiology 33: 17-32.
2. Steen Dalby Kristensen* (Chairperson) (Denmark), Juhani Knuuti* (Chairperson) (Finland), Antti Saraste (Finland), Stefan Anker (Germany), Hans Erik Bøtker (Denmark), Stefan De Hert (Belgium), Ian Ford (UK), Jose Ramo ́ n Gonzalez-Juanatey (Spain), Bulent Gorenek (Turkey), Guy Robert Heyndrickx (Belgium), Andreas Hoeft (Germany), Kurt Huber (Austria), Bernard Iung (France), Keld Per Kjeldsen (Denmark), Dan Longrois (France), Thomas F. Lu ̈ scher (Switzerland), Luc Pierard (Belgium), Stuart Pocock (UK), Susanna Price (UK), Marco Roffi (Switzerland), Per Anton Sirnes (Norway),Miguel Sousa-Uva (Portugal), Vasilis Voudris (Greece), Christian Funck-Brentano (France). 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA) Authors / Task Force Members: European Heart Journal (2014) 35, 2383-2431 ESC/ESA GUIDELINES doi: 10.1093/eurheartj/ehu282.
3. Whitten RA, Bhimji SS. Statin Medications. [Updated 2017 Nov 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun.
4. Stone, Neil J, Robinson, Jennifer G, Lichtenstein, Alice H, Goff, David C, Lloyd-Jones, Donald M, Smith, Sidney C, Blum, Conrad & Schwartz, J Sanford. 2014. Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline. Annals of internal medicine 160: 339-343. 
5. Zhao N, Xu J, Singh B, Yu X, Wu T, Huang Y Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non-cardiac surgery. Cochrane Database of Systematic Reviews 2016, Issue 8. Art. No.: CD010726. DOI: 10.1002/14651858.CD010726.pub2.
6. Zou Z, Yuan HB, Yang B, Xu F, Chen XY, Liu GJ, Shi XY Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adultsCochrane Database of Systematic Reviews 2016, Issue 1. Art. No.: CD009210. DOI: 10.1002/14651858.CD009210.pub2.
7. Guarracino, F, Baldassarri, R & Priebe, HJ. 2015. Revised ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. Implications for preoperative clinical evaluation. Minerva Anestesiol 81: 226-233.
8. Levine, Glenn N, Bates, Eric R, Bittl, John A, Brindis, Ralph G, Fihn, Stephan D, Fleisher, Lee A, Granger, Christopher B, Lange, Richard A, Mack, Michael J & Mauri, Laura. 2016. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation 134: e123-e155.
9. Elyse Bond, Glenn Hurtado, Shanthi Kulasinghe, Thomas Melhuish, Ruan Vlok and Leigh White Management of Novel Oral Anticoagulants in the Perioperative Setting Journal Anesthesia & Critical Care: Volume 8 Issue 4 - 2017.
10.    Dubois, Virginie, Dincq, Anne-Sophie, Douxfils, Jonathan, Ickx, Brigitte, Samama,
Charles-Marc, Dogné, Jean-Michel, Gourdin, Maximilien, Chatelain, Bernard, Mullier, François & Lessire, Sarah. 2017. Perioperative management of patients on direct oral anticoagulants. Thrombosis journal 15: 14.
11.    Raval, Amish N, Cigarroa, Joaquin E, Chung, Mina K, Diaz-Sandoval, Larry J, Diercks, Deborah, Piccini, Jonathan P, Jung, Hee Soo, Washam, Jeffrey B, Welch, Babu G & Zazulia, Allyson R. 2017. Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement from the American Heart Association. Circulation 135: e604-e633.
12.    Ruff, Christian T, Giugliano, Robert P & Antman, Elliott M. 2016. Management of BleedingWith Non=Vitamin K Antagonist Oral Anticoagulants in the Era of sunkara, Tagore, Ofori, Emmanuel, Zarubin, Vadim, Caughey, Megan E, Gaduputi, Vinaya & Reddy, Madhavi. 2016. Perioperative Management of Direct Oral Anticoagulants (DOACs): A Systemic Review. Health services insights 9: 25. Specific Reversal Agents. Circulation 134: 248-261.
13.    De Herta, Stefan, de Robertisb, Edoardo, Longroisc, Dan & Langenecker, Sibylle Kozek. 2014. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. European Heart Journal 35: 2383-2431.